Insider Selling: Afya (NASDAQ:AFYA) CEO Sells $312,246.00 in Stock

Afya Limited (NASDAQ:AFYA) CEO Virgilio Deloy Capobian Gibbon sold 20,900 shares of Afya stock in a transaction that occurred on Thursday, April 2nd. The stock was sold at an average price of $14.94, for a total value of $312,246.00. Following the completion of the transaction, the chief executive officer directly owned 109,218 shares in the company, valued at approximately $1,631,716.92. This represents a 16.06% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Virgilio Deloy Capobian Gibbon also recently made the following trade(s):

• On Monday, April 6th, Virgilio Deloy Capobian Gibbon sold 770 shares of Afya stock. The stock was sold at an average price of $14.91, for a total value of $11,480.70.
• On Wednesday, April 1st, Virgilio Deloy Capobian Gibbon sold 19,500 shares of Afya stock. The stock was sold at an average price of $14.98, for a total value of $292,110.00.
• On Tuesday, March 31st, Virgilio Deloy Capobian Gibbon sold 2,320 shares of Afya stock. The stock was sold at an average price of $14.92, for a total value of $34,614.40.
• On Thursday, March 26th, Virgilio Deloy Capobian Gibbon sold 800 shares of Afya stock. The stock was sold at an average price of $15.21, for a total value of $12,168.00.
• On Wednesday, March 25th, Virgilio Deloy Capobian Gibbon sold 3,900 shares of Afya stock. The stock was sold at an average price of $15.18, for a total value of $59,202.00.

Afya Price Performance

Afya stock opened at $14.94 on Thursday. The stock’s 50 day moving average is $14.48 and its 200 day moving average is $14.69. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.20 and a quick ratio of 0.98. The firm has a market cap of $1.40 billion, a P/E ratio of 10.23, a P/E/G ratio of 0.67 and a beta of 0.48. Afya Limited has a one year low of $13.00 and a one year high of $19.90.

Afya (NASDAQ:AFYA) last issued its earnings results on Wednesday, March 11th. The company reported $0.41 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.05. The business had revenue of $147.08 million during the quarter, compared to the consensus estimate of $174.74 million. Afya had a return on equity of 18.77% and a net margin of 20.31%. As a group, research analysts expect that Afya Limited will post 1.52 EPS for the current year.

Afya Announces Dividend

The firm also recently announced an annual dividend, which was paid on Monday, April 6th. Shareholders of record on Wednesday, March 25th were issued a $0.656 dividend. This represents a yield of 433.0%. The ex-dividend date was Wednesday, March 25th. Afya’s payout ratio is presently 45.21%.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on AFYA. Weiss Ratings reiterated a “hold (c)” rating on shares of Afya in a report on Wednesday, January 21st. Zacks Research upgraded Afya from a “strong sell” rating to a “hold” rating in a report on Monday, March 9th. Sanford C. Bernstein upgraded Afya to a “market perform” rating in a report on Friday, January 16th. Wall Street Zen upgraded Afya from a “buy” rating to a “strong-buy” rating in a report on Saturday, March 14th. Finally, JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $22.00 target price (down from $24.50) on shares of Afya in a report on Wednesday, January 7th. One research analyst has rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $17.30.

Institutional Investors Weigh In On Afya

Several hedge funds and other institutional investors have recently modified their holdings of AFYA. Doma Perpetual Capital Management LLC increased its holdings in shares of Afya by 50.6% during the third quarter. Doma Perpetual Capital Management LLC now owns 891,639 shares of the company’s stock valued at $13,910,000 after acquiring an additional 299,419 shares in the last quarter. SPX Gestao de Recursos Ltda bought a new stake in shares of Afya during the third quarter valued at approximately $2,895,000. Swedbank AB increased its holdings in shares of Afya by 170.3% during the fourth quarter. Swedbank AB now owns 189,200 shares of the company’s stock valued at $2,916,000 after acquiring an additional 119,200 shares in the last quarter. Jump Financial LLC bought a new stake in shares of Afya during the second quarter valued at approximately $731,000. Finally, Qube Research & Technologies Ltd bought a new stake in shares of Afya during the third quarter valued at approximately $610,000. Institutional investors own 88.02% of the company’s stock.

About Afya

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.